You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 貝康醫療-B(2170.HK)漲逾4% 核心產品PGT-A有望放量 機構唱多
格隆匯 09-03 13:47
格隆匯9月3日丨貝康醫療-B(2170.HK)漲逾4%,報11.96港元,總市值33億港元。貝康醫療此前公佈了其2021年中期業績,公司收入增加56.0%至人民幣5016萬元。該增加主要是由於PGT-A試劑盒、儀器及CNV試劑盒的銷量較2020年同期分別增加168%、126%及139%。中金8月31日發佈業績點評稱,貝康醫療上半年收入快速增長,毛利率明顯提升。鼓勵生育的大背景下,隨着拿到PGT許可證生殖診所變多以及貝康進駐生殖診所家數變多,看好PGT-A放量。中金預計貝康醫療2022年或將扭虧為盈,維持“跑贏行業”評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account